Lineage Cell Therapeutics, Inc. Gains 40.22%

Thu, Apr 22, 2021 at 05:30 PM
Lineage Cell Therapeutics, Inc. Gains 40.22%

Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) jumped higher at $12.48, representing a gain of 40.2%. On Wed, Apr 21, 2021, BTX:NYSEMKT touched a New 2-Week Intraday High of $9.84. The stock appeared on our News Catalysts scanner on Mon, Apr 19, 2021 at 06:23 PM in the 'PRIVATE PLACEMENT' category. From Wed, Apr 07, 2021, the stock recorded 60.00% Up Days and 36.36% Green Days

About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)

BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.